Thus, the finding that GW4869 mitigated the sevoflurane-induced changes in tau trafficking and cognitive impairment in mice suggests a role of EVs-associated tau trafficking in AD neuropathogenesis and cognitive function. Here, MAPT is linked to Alzheimer disease.